Effects of bFGF-gene modified skeletal muscle satellite cell transplantation on cardiac function of acute myocardial infarction rabbits
Zhifeng XU,Jinglai LI,Zhen HAN,Gang FENG,Mingming REN
DOI: https://doi.org/10.3969/j.issn.1673-6583.2017.03.009
2017-01-01
Abstract:Objective:To observe the survival of bFGF gene modified skeletal muscle satellite cells in myocardial infarction areas and the effects on cardiac function.Methods:Rabbit skeletal muscle satellite cells were isolated and bFGF gene modified skeletal muscle satellite cells were constructed.Eighteen rabbits with acute myocardial infarction were divided into 3 groups by random: skeletal muscle satellite cell group, bFGF gene modified skeletal muscle satellite cell group and control group.The skeletal muscle satellite cells, bFGF gene modified skeletal muscle satellite cells and an equivalent amount of culture medium were injected into the local infarct myocardium correspondingly.Before modeling and at 4 weeks after cell transplantation, left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), fraction shortening (FS), and ejection fraction (EF) were measured by echocardiography.The survival of skeletal muscle satellite cells, the expression of bFGF gene and the neovascularization in margin area of myocardial infarction were observed in the heart sections at 4 weeks after cell transplantation.Results:Pathological examination at 4 weeks after cell transplantion showed that skeletal muscle satellite cells survived in the margin of myocardial infarction, and EGFP-bFGF fusion protein was highly expressed in bFGF gene modified skeletal muscle satellite cell group.The microvessel density (MVD) in the margin of myocardial infarction in skeletal muscle satellite cell group and bFGF gene modified skeletal muscle satellite cell group was more intensive than that in control group (78.3±5.2 and 98.5±8.6 vs.25.2±4.6, both P<0.05), and the MVD in bFGF gene modified skeletal muscle satellite cell group was higher than that in skeletal muscle satellite cell group (P<0.05).In control group and skeletal muscle satellite cell group, the LVESD and LVEDD at 4 weeks after transplantation were higher than those before modeling, while the FS and EF were lower (all P<0.05).There was no significant difference between these indexes before modeling and at 4 weeks after cell transplantation in bFGF gene modified skeletal muscle satellite cell group.At 4 weeks after transplantation, the LVESD and LVEDD in skeletal muscle satellite cell group and bFGF gene modified skeletal muscle satellite cell group were both lower than those in control group, while the FS and EF were higher (all P<0.05).Compared with skeletal muscle satellite cell group, the LVESD and LVEDD in bFGF gene modified skeletal muscle satellite cell group decreased, while the FS and EF increased significantly (all P<0.05).Conclusion:Autotransplantation of bFGF gene modified skeletal muscle satellite cells can promote angiogenesis in margin area of infarction and improve cardiac function in rabbit with acute myocardial infarction.
What problem does this paper attempt to address?